Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides.
$0.44 +0.00 (0.02%)
As of 05/20/2022 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.